Royalty Pharma plc (NASDAQ:RPRX) Q2 2023 Earnings Call Transcript

Royalty Pharma plc (NASDAQ:RPRX) Q2 2023 Earnings Call Transcript August 8, 2023

Royalty Pharma plc beats earnings expectations. Reported EPS is $0.84, expectations were $0.83.

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma second quarter earnings conference call. I would now like to turn the call over to George Grofik, Senior Vice President, Head of Investor Relations and Communications. Please go ahead, sir.

George Grofik: Good morning and good...